The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 494.00
Bid: 488.00
Ask: 500.00
Change: 0.00 (0.00%)
Spread: 12.00 (2.459%)
Open: 494.00
High: 0.00
Low: 0.00
Prev. Close: 494.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update - Nexus

18 Feb 2020 07:00

RNS Number : 2593D
B.P. Marsh & Partners PLC
18 February 2020
 

18 February 2020

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

Investee Company Update - Nexus Underwriting Management Limited

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist investor in early stage financial services businesses, is pleased to note that its investee company Nexus Underwriting Management Limited ("Nexus"), has been ranked at number 78 in The Sunday Times International Track 200 league table, which ranks Britain's 200 mid-market private companies in order of fastest growing international sales.

 

This is a prestigious group of fast growing companies across all sectors of UK business. Nexus has eight overseas offices across Europe, America and Asia. Nexus increased its international sales to £7.6m for its year ended 31st December 2018, a significant increase from £3.2m for their year ended 31st December 2016.

 

The Group holds an aggregate Nexus shareholding of 17.7% and has been invested since August 2014. Nexus is one of the largest independently owned Managing General Agencies in the UK insurance market, budgeting to write over £345m of Gross Written Premium across various specialty lines in the 2020 financial year.

 

Dan Topping, B.P. Marsh's Chief Investment Officer and Nominee Director on the Board of Nexus has said: "B.P. Marsh is pleased to note this accolade for Nexus, which is a testimony to Nexus' ability to deliver strong growth in international sales and expand their global footprint."

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE / Harriett Osmond - Investor Relations

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon (UK) Limited

Atholl Tweedie / Charles Leigh-Pemberton / Ailsa Macmaster

+44 (0)20 7886 2500

 

Financial PR

Tavistock Communications Limited

Simon Hudson / Tim Pearson

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

Since formation over 25 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

Since its inception B.P. Marsh has delivered an average annual compound increase in NAV of over 10% and this remains one of the Group's core goals for future years.

- Ends -

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKKOBDABKDNBD
Date   Source Headline
22nd Aug 20233:19 pmRNSTransaction in Own Shares
21st Aug 20234:12 pmRNSTransaction in Own Shares
18th Aug 20235:06 pmRNSTransaction in Own Shares
17th Aug 20235:25 pmRNSTransaction in Own Shares
16th Aug 202311:41 amRNSTransaction in Own Shares
15th Aug 202311:54 amRNSTransaction in Own Shares
11th Aug 202312:21 pmRNSTransaction in Own Shares
10th Aug 20239:28 amRNSTransaction in Own Shares
9th Aug 20233:24 pmRNSTransaction in Own Shares
9th Aug 20231:44 pmRNSInvestee Company Update - LEBC
8th Aug 20235:23 pmRNSHolding(s) in Company
7th Aug 20234:25 pmRNSShare Buy-Back Policy
4th Aug 20234:00 pmRNSPDMR and Director Dealings
3rd Aug 20238:58 amRNSTransaction in Own Shares
1st Aug 20235:00 pmRNSTransaction in Own Shares
31st Jul 20232:17 pmRNSTransaction in Own Shares
26th Jul 20234:07 pmRNSResult of AGM
25th Jul 20234:22 pmRNSTransaction in Own Shares
25th Jul 20233:25 pmRNSTransaction in Own Shares
21st Jul 20231:17 pmRNSTransaction in Own Shares
19th Jul 20233:44 pmRNSTransaction in Own Shares
18th Jul 202311:36 amRNSTransaction in Own Shares
11th Jul 20234:02 pmRNSTransaction in Own Shares
10th Jul 20232:41 pmRNSTransaction in Own Shares
30th Jun 202312:05 pmRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSNotice of AGM
27th Jun 20233:06 pmRNSTransaction in Own Shares
26th Jun 202311:43 amRNSTransaction in Own Shares
22nd Jun 202310:59 amRNSTransaction in Own Shares
21st Jun 20231:10 pmRNSNew Investment – Pantheon Specialty Limited
21st Jun 202311:53 amRNSTransaction in Own Shares
19th Jun 20231:15 pmRNSTransaction in Own Shares
13th Jun 202312:08 pmRNSDividend payment date correction
13th Jun 20237:00 amRNSFinal Results
7th Jun 20235:39 pmRNSHolding(s) in Company
6th Jun 20234:05 pmRNSTransaction in Own Shares
6th Jun 20237:00 amRNSUse of Proceeds of Sale & Strategy Update
30th May 202310:18 amRNSTransaction in Own Shares
26th May 20239:40 amRNSTransaction in Own Shares
25th May 20233:11 pmRNSTransaction in Own Shares
23rd May 20232:49 pmRNSNotice of Annual Results and Investor Presentation
23rd May 20237:00 amRNSSale of Shareholding in Kentro Capital Limited
15th May 202310:59 amRNSTransaction in Own Shares
28th Apr 20235:11 pmRNSTransaction in Own Shares
28th Apr 20232:01 pmRNSNew Investment
26th Apr 20234:26 pmRNSTransaction in Own Shares
25th Apr 20235:42 pmRNSTransaction in Own Shares
25th Apr 20237:00 amRNSShare Buy-Back Programme Update
20th Apr 20234:49 pmRNSDirector/PDMR Shareholding
20th Apr 20233:10 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.